Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Lilly meets sales expectations, but Novo gains on PBM win
Last week
Pharma
Exclusive: Ex-Calico scientist launches Stately Bio with new way to study cells
Last week
Financing
AI
Amicus grabs Dimerix’s rare kidney disease drug for $30M upfront
Last week
Deals
Pharma
Moderna expands effort to rein in costs in an ‘uncertain environment’
Last week
R&D
Pharma
Teladoc buys virtual therapy startup UpLift for $30M
Last week
Deals
Health Tech
BeiGene scores a win from US Patent Office in spat over Brukinsa
Last week
Pharma
Law
Exits continue at FDA, as more staff in drug office follow fired colleagues out the door
Last week
People
FDA+
Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments
Last week
Pharma
Law
Scientists alarmed about future of cancer research; TIGIT, CAR-NK and more from #AACR25
Last week
R&D
The Endpoints Slack interview: Arc Institute's Patrick Hsu on investing, AI and new ways of research
Last week
People
AI
Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs
Last week
News Briefing
FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB
Last week
Pharma
FDA+
Updated: Novartis to buy Regulus Therapeutics for up to $1.7B
Last week
Deals
Pharma
GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says
Last week
Pharma
Manufacturing
BridgeBio’s Attruby outperforms sales expectations, shares rise
Last week
Pharma
Exclusive: Noma Therapy raises $4M for virtual ketamine-assisted therapy
Last week
Financing
Health Tech
Artios drug exploits ‘replication stress’ in cancer, shrinking subset of tumors in early study
Last week
Startups
R&D
Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies
Last week
China
Pharma
Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’
Last week
Editor's note
Pharma
Inside Devoted Health’s 2024 financials
Last week
Health Tech
Merck plans to bring Keytruda production to the US with $1B biologics factory
Last week
Manufacturing
FDA approves Abeona’s skin disease cell therapy
Last week
Pharma
Cell/Gene Tx
FDA won't reorganize medical product centers, Makary says in interview: 'I rejected that proposal'
Last week
FDA+
AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data
Last week
News Briefing
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page